Increased systemic sST2 in patients with end stage renal disease contributes to milder liver damage during HCV infection

Ruzica Lukic; Maja Cupic; Nevena Gajovic; Milena Jurisevic; Zeljko Mijailovic; Bojana Davidovic; Bojan Kujundzic; Bojan Joksimovic; Nebojsa Arsenijevic; Ivan Jovanovic

doi:10.3855/jidc.11741

Increased systemic sST2 in patients with end stage renal disease contributes to milder liver damage during HCV infection

Authors

Ruzica Lukic Department of Microbiology, Faculty of Medicine Foča, University of East Sarajevo, Foča, Bosnia and Herzegovina
Maja Cupic Department of Microbiology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Nevena Gajovic Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
Milena Jurisevic Department of clinical pharmacy, Faculty of Medical Sciences University of Kragujevac, Kragujevac, Serbia
Zeljko Mijailovic Department of infectious diseases, Faculty of Medical Sciences University of Kragujevac, Kragujevac, Serbia
Bojana Davidovic Department of Dentistry, Faculty of Medicine, University of East Sarajevo, Foča, Bosnia and Herzegovina
Bojan Kujundzic Department of Dentistry, Faculty of Medicine, University of East Sarajevo, Foča, Bosnia and Herzegovina
Bojan Joksimovic Pediatric Department, Faculty of Medicine Foča, University of East Sarajevo, Foča, Bosnia and Herzegovina
Nebojsa Arsenijevic Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
Ivan Jovanovic Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia

DOI:

https://doi.org/10.3855/jidc.11741

Keywords:

HCV, end-stage renal disease, sST2

Abstract

Introduction: Hepatitis C Virus (HCV) is the leading cause of chronic liver disease and is a serious global health problem. Hepatitis C infection is highly prevalent in patients with end stage renal disease (ESRD), due to frequent exposure to blood and blood products, nosocomial transmission of HCV, and prolong hemodialysis duration. The aim of the study was to evaluate the influence of IL-33/ST2 signaling pathway on severity of the liver disease in ESRD HCV⁺ patients.

Methodology: Blood samples from patients with end stage renal disease (ESRD) and hepatitis C infection (HCV), 20 patients with HCV infection, 20 patients with ESRD and 20 healthy control donor patients were taken for the examination of biochemical parameters, for the determination of the serum cytokine concentration, and for the molecular diagnostics of HCV.

Results: Systemic sST2 positively correlated with serum level of urea and creatinine, respectively. Serum sST2 was significantly increased in ESRD HCV+ patients in comparison to HCV+ group. sST2/IL-1, sST2/IL-4 and sST2/IL-23 ratios were significantly increased in serum of ESRD HCV+ patients in comparison to HCV+ patients. Significantly higher systemic level of sST2 and sST2/IL-1 and sST2/IL-4 ratios were measured in ESRD patients compared to non-ESRD patients.

Conclusion: These results suggested that elevated level sST2, as the consequence of renal failure, causes less destruction of liver in HCV infection.

Downloads

Published

2020-05-31

How to Cite

Lukic R, Cupic M, Gajovic N, Jurisevic M, Mijailovic Z, Davidovic B, Kujundzic B, Joksimovic B, Arsenijevic N, Jovanovic I (2020) Increased systemic sST2 in patients with end stage renal disease contributes to milder liver damage during HCV infection. J Infect Dev Ctries 14:519–526. doi: 10.3855/jidc.11741

Download Citation

Endnote/Zotero/Mendeley (RIS)

Issue

Vol. 14 No. 05: May 2020

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).